Home » Stocks » Aziyo Biologics

Aziyo Biologics, Inc. (AZYO)

Stock Price: $11.38 USD -0.37 (-3.15%)
Updated Oct 21, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 116.37M
Revenue (ttm) 41.63M
Net Income (ttm) -15.63M
Shares Out 10.23M
EPS (ttm) -1.53
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 21, 2020
Last Price $11.38
Previous Close $11.75
Change ($) -0.37
Change (%) -3.15%
Day's Open 11.67
Day's Range 11.23 - 11.58
Day's Volume 32,410
52-Week Range 11.23 - 18.00

More Stats

Market Cap 116.37M
Enterprise Value 166.72M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 10.23M
Float 2.45M
EPS (basic) n/a
EPS (diluted) -1.53
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 2.80
PB Ratio n/a
Revenue 41.63M
Operating Income n/a
Net Income -15.63M
Free Cash Flow n/a
Net Cash -50.35M
Net Cash / Share -4.92
Gross Margin 47.48%
Operating Margin n/a
Profit Margin -37.53%
FCF Margin n/a
ROA n/a
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth9.9%-
Gross Profit19.7715.95
Operating Income-8.41-8.22
Net Income-11.94-11.57
Shares Outstanding0.650.63
Earnings Per Share-18.48-18.37
Operating Cash Flow-7.23-5.45
Capital Expenditures-0.58-0.19
Free Cash Flow-7.80-5.64
Cash & Equivalents2.592.41
Total Debt44.8839.71
Net Cash / Debt-42.29-37.30
Book Value-55.11-43.41
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Aziyo Biologics, Inc.
Country United States
Employees 150
CEO Ronald K. Lloyd

Stock Information

Ticker Symbol AZYO
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: AZYO
IPO Date October 8, 2020


Aziyo Biologics, a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo, a biological envelope that remodels into vascularized tissue for the long-term pocket protection of certain cardiac and neurostimulator implantable electronic devices; and ProxiCor, Tyke, and VasCure, which are a portfolio of extracellular matrices that retain the natural composition of collagen, growth factors, and proteins for use in vascular and cardiac repair, and pericardial closure. The company also provides FiberCel, ViBone, and OsterGro V that are viable matrices designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated human cellular dermal matrix designed to meet a range of surgical needs. In addition, it offers contract manufacturing services for various products to corporate customers. The company sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. Aziyo Biologics, Inc. was founded in 2015 and is headquartered in Silver Spring, Maryland. It has additional offices in Roswell, Georgia; and Richmond, California